Switch to:
More From Other Websites
Most active Nasdaq-traded stocks Sep 19 2014
Why Exelixis (EXEL) Stock Might be a Great Pick Sep 18 2014
Exelixis Announces Cobimetinib Phase 3 coBRIM Results to Be Presented at ESMO 2014 Congress Sep 17 2014
Exelixis to Present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 9 Sep 08 2014
EXELIXIS, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities Sep 05 2014
Exelixis Slumps 55% on Disappointing Cabozantinib Results Sep 03 2014
Exelixis (EXEL) Enters Oversold Territory Sep 03 2014
Exelixis Plunges On Drug Trial Failure; Investors See Potential Sep 02 2014
US STOCKS-Wall St little changed after August rally, data Sep 02 2014
After the Exelixis Implosion, Is There Anything Left Ahead? Sep 02 2014
Why Exelixis (EXEL) Stock Plunged to a One-Year Low Today Sep 02 2014
Exelixis Drug Fails Pivotal Prostate Cancer Study Sep 02 2014
Ahead of the Bell: Exelixis shares tumble Sep 02 2014
Ahead of the Bell: Exelixis shares tumble Sep 02 2014
US STOCKS-Wall St set for flat open; manufacturing data on tap Sep 02 2014
US STOCKS-Wall St set for flat open; manufacturing data on tap Sep 02 2014
Exelixis downgraded by Stifel Sep 02 2014
US STOCKS-Futures inch higher ahead of manufacturing data Sep 02 2014
US STOCKS-Futures inch higher ahead of manufacturing data Sep 02 2014
Exelixis to cut jobs after prostate cancer drug fails late-stage study Sep 01 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK